Usefulness of pT1 substaging in papillary urothelial bladder carcinoma

Diagnostic Pathology

Volumn 11, Issue 1, 2016, Pages

  Patriarca, Carlo ^a   Hurle, Rodolfo ^b   Moschini, Marco ^c   Freschi, Massimo ^c   Colombo, Piergiuseppe ^b   Colecchia, Maurizio ^d   Ferrari, Lucia ^a   Guazzoni, Giorgio ^b   Conti, Andrea ^a   Conti, Giario ^a   Lucianò, Roberta ^c   Magnani, Tiziana ^d   Colombo, Renzo ^c  

^a SANT ANNA HOSPITAL   (Italy)

^b HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^c SAN RAFFAELE HOSPITAL   (Italy)

^d NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Prognosis; Progression; Stage; Substaging system; Urothelial bladder carcinoma

Indexed keywords

AGED; CANCER STAGING; CARCINOMA, PAPILLARY; CLINICAL TRIAL; COMPARATIVE STUDY; CYSTECTOMY; DECISION SUPPORT SYSTEM; DISEASE COURSE; DISEASE FREE SURVIVAL; EVALUATION STUDY; FEASIBILITY STUDY; FEMALE; HUMAN; ITALY; KAPLAN MEIER METHOD; MALE; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; PATHOLOGY; PREDICTIVE VALUE; PROCEDURES; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; RISK FACTOR; SECONDARY; TIME FACTOR; TREATMENT OUTCOME; TUMOR INVASION; TUMOR RECURRENCE; URINARY BLADDER NEOPLASMS; UROTHELIUM;

AGED; CARCINOMA, PAPILLARY; CYSTECTOMY; DECISION SUPPORT TECHNIQUES; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEASIBILITY STUDIES; FEMALE; HUMANS; ITALY; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS; UROTHELIUM;

EID: 84954442427     PISSN: None     EISSN: 17461596     Source Type: Journal    
DOI: 10.1186/s13000-016-0466-6     Document Type: Article

References (23)

1. WHO Classification of Tumours. In: John E, Guido S, Jonathan E, Sesterhenn IA, editors. Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs. Lyon: IARC Press; 2004.
2. Kulkarni GS, Hakenberg OW, Gschwend JE, Thalmann G, Kassouf W, Kamat A. Zlotta. An updated critical analysis of the treatment strategy for newly diagnosed high-grade T1 (previously T1G3) bladder cancer. Eur Urol. 2010;57(1):60-70.
3. Malavaud B. T1G3 bladder tumours: the case for radical cystectomy. Eur Urol. 2004;45(4):406-10.
4. Nigwekar P, Amin MB. The many faces of urothelial carcinoma: an update with an emphasis on recently described variants. Adv Anat Pathol. 2008;15(4):218-33.
5. Jimenez RE, Gheiler E, Oskanian P, Tiguert R, Sakl W, David P, et al. Grading the invasive component of urothelial carcinoma of the bladder and its relationship with progression-free survival. Am J Surg Pathol. 2000;24(7):980-7.
6. Cho KS, Seo HK, Joung JY, Park WS, Ro JY, Han KS, et al. Lymphovascular invasion in transurethral resection specimens as predictor of progression and metastasis in patients with newly diagnosed T1 bladder urothelial cancer. J Urol. 2009;182(6):2625-30.
7. Palou J, Rodríguez-Rubio F, Millán F, Algaba F, Rodríguez-Faba O, Huguet J, et al. Recurrence at three months and high-grade recurrence as prognostic factor of progression in multivariate analysis of T1G2 bladder tumors. Urology. 2009;73(6):1313-7.
8. AJCC Cancer Staging Manual VII ed. Springer 2010.
9. Amin MB, McKenney JK, Paner GP, Hansel DE, Grignon DJ, Montironi R, et al. International consultation on urologic disease - European Association of Urology Consultation on Bladder Cancer 2012. Eur Urol. 2013;63(1):16-35.
10. Orsola A, Trias I, Raventós CX, Español I, Cecchini L, Búcar S, et al. Initial high-grade T1 urothelial cell carcinoma: feasibility and prognostic significance of lamina propria invasion microstaging (T1a/b/c) in BCG-treated and BCG-non-treated patients. Eur Urol. 2005;48(2):231-8.
11. Angulo JC, Lopez JI. The importance of the depth of invasion in stage T1 bladder carcinoma: a prospective cohort study. J Urol. 1997;158(5):1922.
12. Chang WC, Chang YH, Pan CC. Prognostic significance in substaging of T1 urinary bladder urothelial carcinoma on transurethral resection. Am J Surg Pathol. 2012;36(3):454-61.
13. van Rhijn BW, van der Kwast TH, Alkhateeb SS, Fleshner NE, van Leenders GJ, Bostrom PJ, et al. A new and highly prognostic system to discern T1 bladder cancer substage. Eur Urol. 2012;61(2):378-84.
14. Bertz S, Denzinger S, Otto W, Wieland WF, Stoehr R, Hofstaedter F, et al. Substaging by estimating the size of invasive tumour can improve risk stratification in pT1 urothelial bladder cancer - evaluation of a large hospital-based single-centre series. Histopathology. 2011;59(4):722-32.
15. Cheng L, Lopez-Beltran A, Bostwick DG. Bladder Pathology, Chapter 120. New Jersey, US: Wiley -Blackwel. 2012;194-213.
16. Paner GP, Ro JY, Wojcik EM, Venkataraman G, Datta MW, Amin MB. Further characterization of the muscle layers and lamina propria of the urinary bladder by systematic histologic mapping: implications for pathologic staging of invasive urothelial carcinoma. Am J Surg Pathol. 2007;31(9):1420-9.
17. Compérat E, Egevad L, Lopez-Beltran A, Camparo P, Algaba F, Amin M, et al. An interobserver reproducibility study on invasiveness of bladder cancer using virtual microscopy and heatmaps. Histopathology. 2013;63(6):756-66.
18. Martin-Doyle W, Leow JJ, Orsola A, Chang SL, Bellmunt J. Improving selection criteria for early cystectomy in high-grade T1 bladder cancer: a meta-analysis of 15,215 patients. J Clin Oncol. 2015;33(6):643-50.
19. Cheng L, Neumann RM, Weaver AL, Spotts BE, Bostwick DG. Predicting cancer progression in patients with stage T1 bladder carcinoma. J Clin Oncol. 1999;17(10):3182-7.
20. Paner GP, Brown JG, Lapetino S, Nese N, Gupta R, Shen SS, et al. Diagnostic use of antibody to smoothelin in the recognition of muscularis propria in transurethral resection of urinary bladder tumor (TURBT) specimens. Am J Surg Pathol. 2010;34(6):792-9.
21. Brimo F, Chenbo W, Zeizafoun N, Tanguay S, Aprikina A, Mansure JJ, et al. Prognostic factors in T1 bladder urothelial carcinoma: the value of recording millimetric depth of invasion, diameter of invasive carcinoma, and muscolaris mucosae invasion. Hum Pathol. 2013;44:95-102.
22. Ukai R, Hashimoto K, Iwasa T, Nakayama H. Transurethral resection in one piece (TURBO) is an accurate tool for pathological staging of bladder tumor. Int J Urol. 2010;17(8):708-14.
23. Kramer MW, Rassweiler JJ, Klein J, Martov A, Baykov N, Lusuardi L, et al. En bloc resection of urothelium carcinoma of the bladder (EBRUC): a European multicenter study to compare safety, efficacy, and outcome of laser and electrical en bloc transurethral resection of bladder tumor. World J Urol. 2015 Apr 25. [Epub ahead of print].